Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
National supply may be adequate while local pharmacies experience shortages Distribution bottlenecks affect product availability at individual pharmacies Patients seek compounded alternatives whenever facing access barriers Supply chain disruptions lead to varying availability across regions FDA monitors supply-demand interactions while allowing temporary compounding These interactions create a complex landscape where patients and healthcare providers must navigate between branded medications and compounded alternatives, often balancing availability with access considerations
Wood for providing Polq -/- mouse cells
People enrolled in government programs, such as Medicare and Medicaid, are not eligible for the Savings Offer
Sponsored by Eli Lilly, this trial represents the single most important study in the retatrutide development program
US$ 26.40
US$ 29.05
US$ 26.46
US$ 20.95
